Biotech Development Center (BDC)

Biotech Development Center (BDC)

REFERENCE PROJECT

Biotech Development Center (BDC)

The Merck Biotech Development Center represents an investment of more than 250 million euros which aims to contribute to speed up the availability of new medicines for patients with unmet medical needs, in particular in the area of cancer. This new site also confirms Switzerland – and most particularly the Lake Geneva area – as Merck’s prime hub for the manufacturing and development of biotech medicines for patients from all over the world. To meet the requirements for sustainability, manage energy efficiency and optimize the use of natural daylight, the BDC will benefit from the unique innovative technology of eyrise® dynamic liquid crystal glazing. The dynamic glass used is eyrise®s350 instant solar shading for the façade and eyrise® i350 transparent privacy glazing for the interiors.

  • Location –
    Corsier-sur-Vevey, Switzerland
  • Building Owner –
    Merck KGaA
  • Architect –
    Patriarche Architekten
  • Facade Contractor –
    Sottas SA
  • Installation Date –
    2022
  • Product:
    eyrise® s350 Instant Solar Shading Glass
  • Surface:
    1826 m²
  • Quantity:
    456
  • Geometry:
    Rectangles
  • Type:
    Triple Glazing
  • Color:
    Neutral grey Mixture E
  • Product:
    eyrise® i350 Invisible Privacy Glazing
  • Surface:
    378 m²
  • Quantity:
    142

GALLERY

Project Gallery

Biotech Development Center (BDC)
Biotech Development Center (BDC)
Biotech Development Center (BDC)
Biotech Development Center (BDC)
eyrise at BDC
Biotech Development Center (BDC)
Biotech Development Center (BDC) 5
Biotech Development Center (BDC) 5

VIEW MORE PROJECTS.

CONTACT

Contact Us

Send us e-mail

Write us an e-mail, using e-mail app
Send e-mail

Start a Conversation

Use our chatbot or schedule a call

Use Contact Form

Write us through contact form
Fill The Form
merc-logo
© 2022 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. Merck, the vibrant M, eyrise and Licrivision are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources.